(Q37362723)

19 August 2017

1 reference

title

Percutaneous coronary interventions and statins therapy (English)

1 reference

19 August 2017

Annunziata Nusca

1

1 reference

19 August 2017

Rosetta Melfi

series ordinal

2

1 reference

19 August 2017

Germano Di Sciascio

series ordinal

3

1 reference

19 August 2017

language of work or name

1 reference

1 April 2008

1 reference

Therapeutic advances in cardiovascular disease

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

2

1 reference

19 August 2017

101-107

1 reference

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Statin effects beyond lipid lowering--are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Frequency and long-term impact of myonecrosis after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Beneficial cardiovascular pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708089983

21 January 2018

Identifiers

DOI

10.1177/1753944708089983

1 reference

19 August 2017

1 reference